Education
About Us
Working with TipRanks
Follow Us
Lineage Cell Therapeutics, Inc. (GB:0HNF)
LSE:0HNF
Lineage Therap (0HNF) Ownership Overview
58.75% Insiders
5.98%
Mutual Funds
2.94% Other Institutional Investors
7.20% ETFs
25.13% Public Companies and Individual Investors
The ownership structure of Lineage Therap (GB:0HNF) stock is a mix of institutional, retail, and individual investors. Approximately 16.12% of the company’s stock is owned by Institutional Investors, 58.75% is owned by Insiders, and 25.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 28, 2025 | xxxxxxxxxxxxx | $6000000 | |
Nov 26, 2024 | xxxxxxxxxxxxx | $9000 | |
Nov 26, 2024 | xxxxxxxxxxxxx | $8850 | |
Nov 25, 2024 | xxxxxxxxxxxxx | $22400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $2544581 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2846203 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 99,209,612 | Insider | 43.45% | 124,012,015 | |
| 34,093,007 | Insider | 14.93% | 42,616,259 | |
| 8,439,936 | Institution | 3.70% | 10,549,920 | |
| 7,236,843 | Institution | 3.17% | 9,046,054 | |
| 7,231,398 | Institution | 3.17% | 9,039,248 | |
| 6,310,873 | Institution | 2.76% | 7,888,591 | |
| 6,211,045 | Institution | 2.72% | 7,763,806 | |
| 5,492,088 | Institution | 2.41% | 6,865,110 | |
| 1,632,230 | Institution | 0.71% | 2,040,288 | |
| 1,609,804 | Institution | 0.70% | 2,012,255 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,231,398 | Institution | 3.17% | 9,039,248 | |
| 1,632,230 | Institution | 0.71% | 2,040,288 | |
| 1,609,804 | Institution | 0.70% | 2,012,255 | |
| 894,040 | Institution | 0.39% | 1,117,550 | |
| 820,126 | Institution | 0.36% | 1,025,158 | |
| 417,900 | Institution | 0.18% | 522,375 | |
| 416,223 | Institution | 0.18% | 520,279 | |
| 128,266 | Institution | 0.06% | 160,333 | |
| 93,589 | Institution | 0.04% | 116,986 | |
| 70,884 | Institution | 0.03% | 88,605 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Lineage Cell Therapeutics, Inc. (GB:0HNF)?
According to the latest TipRanks data, approximately 2.94% of the company's stock is held by institutional investors, 58.75% is held by insiders, and 25.13% is held by retail investors.
What percentage of Lineage Cell Therapeutics, Inc. (GB:0HNF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.94% of Lineage Cell Therapeutics, Inc. (GB:0HNF) stock is held by institutional investors.
What percentage of Lineage Cell Therapeutics, Inc. (GB:0HNF) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.13% of Lineage Cell Therapeutics, Inc. (GB:0HNF) stock is held by retail investors.
Who owns the most shares of Lineage Cell Therapeutics, Inc. (GB:0HNF)?
Broadwood Partners Lp owns the most shares of Lineage Cell Therapeutics, Inc. (GB:0HNF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.